CIA
GH icon

CSat Investment Advisory’s Guardant Health GH Stock Holding History

CSat Investment Advisory’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-347
Closed -$39K – 696
2020
Q3 		$39K Buy
347
+41
+13% +$3.75K ﹤0.01% 704
2020
Q2 		$25K Buy
+306
New +$24.7K ﹤0.01% 781

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CSat Investment Advisory's GH Position: Q4 2020 in Review

CSat Investment Advisory sold out of Guardant Health (GH) in Q4 2020, closing a stake of 347 shares — an estimated $39K sold.

CSat Investment Advisory first reported a position in GH in Q2 2020 and held it in 2 quarters. The position peaked at $39K in Q3 2020. 419 funds tracked by Wall St. Rank hold GH as of Q4 2020.

  • CSat Investment Advisory reported no remaining Guardant Health position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 347 Guardant Health shares in Q4 2020, an estimated $39K.
  • CSat Investment Advisory first reported a position in Guardant Health in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's Guardant Health position peaked at $39K in Q3 2020.
  • 419 funds tracked by Wall St. Rank held Guardant Health as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.